Seroatlas · Human Serome Atlas

ACVR2A

Activin receptor type-2A

Also known as: ACTRII, ACVR2, AVR2A_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P27037
Gene
ACVR2A
Ensembl
ENSG00000121989
Chromosome
2
Canonical length
513 aa
Protein class
Cancer-related genes, Enzymes, Predicted membrane proteins
Subcellular location
Cytosol

OverviewNCBI Gene

This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]

Canonical amino-acid sequenceUniProt

513 residues, UniProt reviewed canonical sequence.

>P27037|ACVR2A
     1  MGAAAKLAFA VFLISCSSGA ILGRSETQEC LFFNANWEKD RTNQTGVEPC YGDKDKRRHC
    61  FATWKNISGS IEIVKQGCWL DDINCYDRTD CVEKKDSPEV YFCCCEGNMC NEKFSYFPEM
   121  EVTQPTSNPV TPKPPYYNIL LYSLVPLMLI AGIVICAFWV YRHHKMAYPP VLVPTQDPGP
   181  PPPSPLLGLK PLQLLEVKAR GRFGCVWKAQ LLNEYVAVKI FPIQDKQSWQ NEYEVYSLPG
   241  MKHENILQFI GAEKRGTSVD VDLWLITAFH EKGSLSDFLK ANVVSWNELC HIAETMARGL
   301  AYLHEDIPGL KDGHKPAISH RDIKSKNVLL KNNLTACIAD FGLALKFEAG KSAGDTHGQV
   361  GTRRYMAPEV LEGAINFQRD AFLRIDMYAM GLVLWELASR CTAADGPVDE YMLPFEEEIG
   421  QHPSLEDMQE VVVHKKKRPV LRDYWQKHAG MAMLCETIEE CWDHDAEARL SAGCVGERIT
   481  QMQRLTNIIT TEDIVTVVTM VTNVDFPPKE SSL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ACVR2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.34
Highest tissue expression
18 nTPM

Expression across tissuesHPA

Tissue

  • skin: 18 nTPM
  • skeletal muscle: 16 nTPM
  • small intestine: 8.7 nTPM
  • retina: 7.6 nTPM
  • placenta: 7.3 nTPM
  • duodenum: 7.2 nTPM

Single-cell type

  • fibro-adipogenic progenitors: 163 nCPM
  • sertoli cells: 139 nCPM
  • corticotrophs: 125 nCPM
  • oligodendrocyte progenitor cells: 115 nCPM
  • enterocytes: 104 nCPM
  • brain inhibitory neurons: 104 nCPM

Immune cell

  • NK-cell: 4.8 nTPM
  • memory CD4 T-cell: 2.4 nTPM
  • intermediate monocyte: 2 nTPM
  • non-classical monocyte: 2 nTPM
  • classical monocyte: 1.7 nTPM
  • plasmacytoid DC: 1.7 nTPM

Brain region

  • cerebellum: 28 nTPM
  • hypothalamus: 23 nTPM
  • cerebral cortex: 21 nTPM
  • basal ganglia: 20 nTPM
  • amygdala: 17 nTPM
  • hippocampal formation: 16 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.17
gnomAD pLI
1
gnomAD missense Z
3.29
DepMap mean gene effect
-0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ACVR2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ACVR2A as an antibody target. Whether an autoantibody or antibody against ACVR2A could matter depends on whether native ACVR2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ACVR2A is annotated at the cell surface, where native ACVR2A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label ACVR2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ACVR2A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...